HRP20141192T1 - Humanizirani il-6 i receptor il-6 - Google Patents

Humanizirani il-6 i receptor il-6 Download PDF

Info

Publication number
HRP20141192T1
HRP20141192T1 HRP20141192AT HRP20141192T HRP20141192T1 HR P20141192 T1 HRP20141192 T1 HR P20141192T1 HR P20141192A T HRP20141192A T HR P20141192AT HR P20141192 T HRP20141192 T HR P20141192T HR P20141192 T1 HRP20141192 T1 HR P20141192T1
Authority
HR
Croatia
Prior art keywords
mouse
human
gene
genetically modified
humanized
Prior art date
Application number
HRP20141192AT
Other languages
English (en)
Inventor
Li-Hsien Wang
Anthony T. Dore
Sean Stevens
Andrew J. Murphy
Original Assignee
Regeneron Pharmaceuticals, Inc.
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Regeneron Pharmaceuticals, Inc. filed Critical Regeneron Pharmaceuticals, Inc.
Publication of HRP20141192T1 publication Critical patent/HRP20141192T1/hr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • A01K67/0278—Knock-in vertebrates, e.g. humanised vertebrates
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K67/00—Rearing or breeding animals, not otherwise provided for; New or modified breeds of animals
    • A01K67/027—New or modified breeds of vertebrates
    • A01K67/0275—Genetically modified vertebrates, e.g. transgenic
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5412—IL-6
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants
    • C07K14/715—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons
    • C07K14/7155—Receptors; Cell surface antigens; Cell surface determinants for cytokines; for lymphokines; for interferons for interleukins [IL]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/63—Introduction of foreign genetic material using vectors; Vectors; Use of hosts therefor; Regulation of expression
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/87—Introduction of foreign genetic material using processes not otherwise provided for, e.g. co-transformation
    • C12N15/90—Stable introduction of foreign DNA into chromosome
    • C12N15/902—Stable introduction of foreign DNA into chromosome using homologous recombination
    • C12N15/907—Stable introduction of foreign DNA into chromosome using homologous recombination in mammalian cells
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/06—Animal cells or tissues; Human cells or tissues
    • C12N5/0602—Vertebrate cells
    • C12N5/0603—Embryonic cells ; Embryoid bodies
    • C12N5/0606—Pluripotent embryonic cells, e.g. embryonic stem cells [ES]
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N5/00—Undifferentiated human, animal or plant cells, e.g. cell lines; Tissues; Cultivation or maintenance thereof; Culture media therefor
    • C12N5/10—Cells modified by introduction of foreign genetic material
    • C12N5/12—Fused cells, e.g. hybridomas
    • C12N5/16—Animal cells
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2207/00—Modified animals
    • A01K2207/15—Humanized animals
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/05—Animals comprising random inserted nucleic acids (transgenic)
    • A01K2217/052—Animals comprising random inserted nucleic acids (transgenic) inducing gain of function
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/07—Animals genetically altered by homologous recombination
    • A01K2217/072—Animals genetically altered by homologous recombination maintaining or altering function, i.e. knock in
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2217/00—Genetically modified animals
    • A01K2217/15—Animals comprising multiple alterations of the genome, by transgenesis or homologous recombination, e.g. obtained by cross-breeding
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2227/00—Animals characterised by species
    • A01K2227/10—Mammal
    • A01K2227/105—Murine
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/02—Animal zootechnically ameliorated
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01K—ANIMAL HUSBANDRY; AVICULTURE; APICULTURE; PISCICULTURE; FISHING; REARING OR BREEDING ANIMALS, NOT OTHERWISE PROVIDED FOR; NEW BREEDS OF ANIMALS
    • A01K2267/00—Animals characterised by purpose
    • A01K2267/03—Animal model, e.g. for test or diseases
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K2319/00—Fusion polypeptide

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Biomedical Technology (AREA)
  • Environmental Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Wood Science & Technology (AREA)
  • Toxicology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Cell Biology (AREA)
  • Medicinal Chemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Animal Husbandry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Microbiology (AREA)
  • Immunology (AREA)
  • Physics & Mathematics (AREA)
  • Plant Pathology (AREA)
  • Mycology (AREA)
  • Reproductive Health (AREA)
  • Gynecology & Obstetrics (AREA)
  • Developmental Biology & Embryology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Ultra Sonic Daignosis Equipment (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Claims (17)

1. Genetički modificirani miš koji sadrži zamjenu na lokusu endogenog miša IL-6 mišjeg gena koji kodira IL-6 sa ljudskim genom koji kodira ljudski IL-6, naznačen time da je ljudski gen koji kodira ljudski IL-6 pod kontrolom regulacijskih elemenata endogenog miša na lokusu endogenog miša IL-6.
2. Genetički modificirani miš prema zahtjevu 1, naznačen time da ljudski gen koji kodira ljudski IL-6 sadrži eksone 1 do 5 ljudskog IL-6 gena pronađene u bakterijskom umjetnom kromosomu CTD-2369M23.
3. Genetički modificirani miš prema zahtjevu 1, naznačen time da miš eksprimira mišji IL-6Rα.
4. Genetički modificirani miš prema zahtjevu 1, naznačen time da miš eksprimira humanizirani IL-6Rα pri čemu je endogeni mišji IL-6Rα gen zamijenjen ljudskom sekvencom koja sadrži sekvencu koja kodira ektodomenu za ljudski IL-6Rα.
5. Genetički modificirani miš prema zahtjevu 1, naznačen time da miš ne iskazuje značajku izabranu od plazmocitoze, glomeruloskleroze, glomerulonefritisa, zatajenja bubrega, hipergamaglobulinemiju, povišene megakariocite u slezeni, povišene megakariocite u koštanoj srži, splenomegaliju, uvećanje limfnih čvorova, kompaktne abnormalne stanice plazme, te njihove kombinacije.
6. Genetički modificirani miš prema zahtjevu 4, naznačen time da humanizirani IL-6Rα sadrži ljudsku ektodomenu.
7. Genetički modificirani miš prema zahtjevu 6, naznačen time da humanizirani IL-6Rα sadrži mišju transmembransku domenu i mišju citoplazmatsku domenu.
8. Genetički modificirani miš prema zahtjevu 1, naznačen time da miš sadrži stanicu koja eksprimira IL-6Rα koji sadrži ljudsku ektodomenu na površini stanice.
9. Genetički modificirani miš, koji sadrži humanizaciju endogenog mišjeg IL-6Rα gena, naznačen time da se humanizacija sastoji od zamjene mišje IL-6Rα sekvence koja kodira ektodomenu sa ljudskom IL-6Rα sekvencom koja kodira ektodomenu na lokusu endogenog miša IL-6Rα, te pri čemu je humanizirani IL-6Rα gen pod kontrolom regulacijskih elemenata endogenog miša.
10. Genetički modificirani miš prema zahtjevu 9, naznačen time da je granična mišja sekvenca koja sadrži mišje eksone 1 do 8 zamijenjena sa graničnim genomskim fragmentom ljudske IL-6Rα sekvence koja kodira ljudsku ektodomenu IL-6Rα.
11. Genetički modificirani miš prema zahtjevu 10, naznačen time da je granični genomski fragment ljudske IL-6Rα sekvence koja kodira ektodomenu pronađen u bakterijskom umjetnom kromosomu CTD-2192J23.
12. Genetički modificirani miš prema zahtjevu 9, naznačen time da dodatno sadrži humanizirani IL-6 gen koji sadrži zamjenu na endogenom lokusu mišjeg IL-6 za mišji gen koji kodira IL-6 s ljudskim genom koji kodira ljudski IL-6.
13. Genetički modificirani miš prema zahtjevu 12, naznačen time da je humanizirani IL-6 gen pod kontrolom regulacijskih elemenata endogenog miša.
14. Postupak za stvaranje humaniziranog miša, naznačen time da sadrži zamjenu sekvence mišjeg gena koji kodira mišji IL-6 sa ljudskim genom koji kodira ljudski IL-6 tako da je ljudski IL-6 gen pod kontrolom regulacijskih elemenata endogenog miša.
15. Postupak za stvaranje humaniziranog miša, naznačen time da sadrži zamjenu svih mišjih eksona koji kodiraju sekvence ektodomene za mišji IL-6Rα sa ljudskim genomskim fragmentom koji kodira ljudsku ektodomenu IL-6Rα da se dobije humanizirani IL-6Rα gen, pri čemu je humanizirani IL-6Rα gen pod kontrolom regulacijskih elemenata endogenog miša.
16. Genetički modificirani miš koji sadrži humanizirani IL-6Rα gen koji sadrži zamjenu mišje sekvence koja kodira ektodomenu sa ljudskom sekvencom ektodomene, naznačen time da humanizirani IL-6Rα gen sadrži mišju transmembransku sekvencu i mišju citoplazmatsku sekvencu; pri čemu miš dodatno sadrži gen koji kodira ljudski IL-6, pri čemu su geni koji kodiraju ljudski IL-6 i humanizirani IL-6Rα pod kontrolom regulacijskih elemenata endogenog miša.
17. Genetički modificirani miš prema zahtjevu 16, naznačen time da miš ne eksprimira mišji IL-6Rα i ne eksprimira mišji IL-6.
HRP20141192AT 2011-10-28 2014-12-10 Humanizirani il-6 i receptor il-6 HRP20141192T1 (hr)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
US201161552900P 2011-10-28 2011-10-28
US201161556579P 2011-11-07 2011-11-07
EP12795905.4A EP2663575B1 (en) 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor
PCT/US2012/062379 WO2013063556A1 (en) 2011-10-28 2012-10-29 Humanized il-6 and il-6 receptor

Publications (1)

Publication Number Publication Date
HRP20141192T1 true HRP20141192T1 (hr) 2015-02-13

Family

ID=47295138

Family Applications (2)

Application Number Title Priority Date Filing Date
HRP20141192AT HRP20141192T1 (hr) 2011-10-28 2014-12-10 Humanizirani il-6 i receptor il-6
HRP20170656TT HRP20170656T1 (hr) 2011-10-28 2017-04-28 Humanizirani il-6 i receptor il-6

Family Applications After (1)

Application Number Title Priority Date Filing Date
HRP20170656TT HRP20170656T1 (hr) 2011-10-28 2017-04-28 Humanizirani il-6 i receptor il-6

Country Status (28)

Country Link
US (9) US8878001B2 (hr)
EP (2) EP2663575B1 (hr)
JP (2) JP6120451B2 (hr)
KR (2) KR102084927B1 (hr)
CN (2) CN104039821A (hr)
AU (1) AU2015207889B2 (hr)
BR (1) BR112014008529A2 (hr)
CA (1) CA2853731C (hr)
CY (2) CY1116614T1 (hr)
DK (2) DK2663575T3 (hr)
ES (2) ES2525368T3 (hr)
HK (2) HK1190408A1 (hr)
HR (2) HRP20141192T1 (hr)
HU (1) HUE033400T2 (hr)
IL (4) IL231896B (hr)
IN (1) IN2014CN03920A (hr)
LT (1) LT2818478T (hr)
MX (1) MX358390B (hr)
MY (2) MY172726A (hr)
PL (2) PL2818478T3 (hr)
PT (2) PT2663575E (hr)
RS (2) RS55949B1 (hr)
RU (2) RU2634417C2 (hr)
SG (3) SG10202100485XA (hr)
SI (2) SI2663575T1 (hr)
SM (1) SMT201400187B (hr)
WO (1) WO2013063556A1 (hr)
ZA (1) ZA201402635B (hr)

Families Citing this family (74)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK3056082T3 (en) 2009-10-06 2018-12-17 Regeneron Pharma RE-MODIFIED MICE AND INPUT
ES2948210T3 (es) 2011-02-15 2023-09-06 Regeneron Pharma Ratones humanizados con M-CSF y uso de los mismos
PT2663575E (pt) 2011-10-28 2014-12-05 Regeneron Pharma Il-6 e receptor de il-6 humanizados
US20130261016A1 (en) * 2012-03-28 2013-10-03 Meso Scale Technologies, Llc Diagnostic methods for inflammatory disorders
US8962913B2 (en) 2012-06-18 2015-02-24 Regeneron Pharmaceuticals, Inc. Humanized IL-7 rodents
KR20240045263A (ko) 2012-09-07 2024-04-05 예일 유니버시티 유전적으로 변형된 비-인간 동물 및 이것들의 사용 방법
EP2896291B1 (en) * 2012-09-13 2019-03-20 Chugai Seiyaku Kabushiki Kaisha Gene knock-in non-human animal
EP4389764A3 (en) 2012-11-05 2024-08-14 Regeneron Pharmaceuticals, Inc. Genetically modified non-human animals and methods of use thereof
KR102313047B1 (ko) 2013-02-20 2021-10-19 리제너론 파아마슈티컬스, 인크. 사람화된 ｔ-세포 보조-수용체를 발현하는 마우스
CN105164154B (zh) 2013-02-22 2019-06-07 瑞泽恩制药公司 表达人源化主要组织相容性复合物的小鼠
GB2513884B (en) 2013-05-08 2015-06-17 Univ Bristol Method and apparatus for producing an acoustic field
US9193977B2 (en) 2013-09-23 2015-11-24 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized signal-regulatory protein gene
CA2926090C (en) * 2013-10-15 2022-07-05 Regeneron Pharmaceuticals, Inc. Humanized il-15 animals
ES2703549T3 (es) 2013-11-19 2019-03-11 Regeneron Pharma Animales no humanos que tienen un gen de un ligando inductor de la proliferación humanizado
JP6505689B2 (ja) * 2013-11-19 2019-04-24 リジェネロン・ファーマシューティカルズ・インコーポレイテッドＲｅｇｅｎｅｒｏｎ Ｐｈａｒｍａｃｅｕｔｉｃａｌｓ， Ｉｎｃ． ヒト化ｂ細胞活性化因子遺伝子を有する非ヒト動物
US9612658B2 (en) 2014-01-07 2017-04-04 Ultrahaptics Ip Ltd Method and apparatus for providing tactile sensations
EA033604B1 (ru) 2014-01-31 2019-11-08 Boehringer Ingelheim Int Молекула анти-baff антитела, фармацевтическая композиция, содержащая эту молекулу, способы ее применения и кодирующий ее изолированный полинуклеотид
ES2794942T3 (es) 2014-04-08 2020-11-19 Regeneron Pharma Animales no humanos que tienen receptores Fc-gamma humanizados
NZ726602A (en) 2014-05-05 2024-05-31 Regeneron Pharmaceuticals Inc Humanized c5 and c3 animals
NO2785538T3 (hr) 2014-05-07 2018-08-04
RU2711744C1 (ru) 2014-05-19 2020-01-21 Ридженерон Фармасьютикалз, Инк. Генетически модифицированные животные, отличные от человека, экспрессирующие epo человека
MX2016015609A (es) 2014-05-30 2017-08-02 Regeneron Pharma Animales con dipeptidil peptidasa iv (dpp4) humanizada.
WO2015196051A1 (en) 2014-06-19 2015-12-23 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized programmed cell death 1 gene
GB2530036A (en) 2014-09-09 2016-03-16 Ultrahaptics Ltd Method and apparatus for modulating haptic feedback
CN113016720B (zh) 2014-11-24 2023-02-21 瑞泽恩制药公司 表达人源化cd3复合物的非人类动物
LT3850946T (lt) * 2014-12-05 2024-01-10 Regeneron Pharmaceuticals, Inc. Gyvūnai, išskyrus žmogų, turintys humanizuotą ląstelės diferenciacijos klasterio 47 geną
RU2711729C2 (ru) 2014-12-09 2020-01-21 Регенерон Фармасьютикалз, Инк. Не относящиеся к человеку животные, имеющие гуманизированный ген кластера дифференцировки 274
US9841819B2 (en) 2015-02-20 2017-12-12 Ultrahaptics Ip Ltd Perceptions in a haptic system
KR102524966B1 (ko) 2015-02-20 2023-04-21 울트라햅틱스 아이피 엘티디 햅틱 시스템에서의 알고리즘 개선
AU2016246698B2 (en) 2015-04-06 2022-06-02 Regeneron Pharmaceuticals, Inc. Humanized T cell mediated immune responses in non-human animals
FI3282835T3 (fi) 2015-04-13 2023-07-20 Regeneron Pharma Humanisoituja sirpa-il15-poistogeenisiä hiiriä ja niiden käyttömenetelmiä
US10818162B2 (en) 2015-07-16 2020-10-27 Ultrahaptics Ip Ltd Calibration techniques in haptic systems
WO2017087780A1 (en) 2015-11-20 2017-05-26 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized lymphocyte-activation gene 3
DK3386534T3 (da) 2015-12-08 2020-11-30 Regeneron Pharma Sammensætninger og fremgangsmåder til internalisering af enzymer
US11189140B2 (en) 2016-01-05 2021-11-30 Ultrahaptics Ip Ltd Calibration and detection techniques in haptic systems
WO2017136712A1 (en) 2016-02-04 2017-08-10 Regeneron Pharmaceuticals, Inc. Non-human animals having an engineered angptl8 gene
KR102493894B1 (ko) 2016-02-29 2023-01-31 리제너론 파마슈티칼스 인코포레이티드 인간화 tmprss 유전자를 갖는 설치류
CA3026088A1 (en) 2016-06-03 2017-12-07 Regeneron Pharmaceuticals, Inc. Non-human animals expressing exogenous terminal deoxynucleotidyltransferase
US10531212B2 (en) 2016-06-17 2020-01-07 Ultrahaptics Ip Ltd. Acoustic transducers in haptic systems
US10268275B2 (en) 2016-08-03 2019-04-23 Ultrahaptics Ip Ltd Three-dimensional perceptions in haptic systems
US10755538B2 (en) 2016-08-09 2020-08-25 Ultrahaptics ilP LTD Metamaterials and acoustic lenses in haptic systems
CN107815467B (zh) * 2016-08-31 2021-03-16 百奥赛图(北京)医药科技股份有限公司 人源化基因改造动物模型的制备方法及应用
US10943578B2 (en) 2016-12-13 2021-03-09 Ultrahaptics Ip Ltd Driving techniques for phased-array systems
US10497358B2 (en) 2016-12-23 2019-12-03 Ultrahaptics Ip Ltd Transducer driver
WO2018177441A1 (en) * 2017-03-31 2018-10-04 Beijing Biocytogen Co., Ltd GENETICALLY MODIFIED NON-HUMAN ANIMAL WITH HUMAN OR CHIMERIC SIRPα
CN108588126B (zh) 2017-03-31 2020-04-10 北京百奥赛图基因生物技术有限公司 Cd47基因人源化改造动物模型的制备方法及应用
BR112020003609A2 (pt) 2017-09-29 2020-09-01 Regeneron Pharmaceuticals, Inc. sistema e método para formar uma emulsão
US11531395B2 (en) 2017-11-26 2022-12-20 Ultrahaptics Ip Ltd Haptic effects from focused acoustic fields
KR102709884B1 (ko) 2017-11-30 2024-09-26 리제너론 파마슈티칼스 인코포레이티드 인간화된 trkb 유전자좌를 포함하는 비인간 동물
WO2019122912A1 (en) 2017-12-22 2019-06-27 Ultrahaptics Limited Tracking in haptic systems
JP7483610B2 (ja) 2017-12-22 2024-05-15 ウルトラハプティクス アイピー リミテッド 触覚システムにおける不要な応答の最小化
JP7328243B2 (ja) 2018-03-26 2023-08-16 リジェネロン・ファーマシューティカルズ・インコーポレイテッド 治療薬を試験するためのヒト化げっ歯類
SG11202010752VA (en) 2018-05-02 2020-11-27 Ultrahaptics Ip Ltd Blocking plate structure for improved acoustic transmission efficiency
US11589562B2 (en) * 2018-07-16 2023-02-28 Regeneran Pharmaceuticals, Inc. Mouse model of DITRA disease and uses thereof
US11098951B2 (en) 2018-09-09 2021-08-24 Ultrahaptics Ip Ltd Ultrasonic-assisted liquid manipulation
US11378997B2 (en) 2018-10-12 2022-07-05 Ultrahaptics Ip Ltd Variable phase and frequency pulse-width modulation technique
US20220015343A1 (en) * 2018-12-17 2022-01-20 Biocytogen Pharmaceuticals (Beijing) Co., Ltd. Genetically modified non-human animal with human or chimeric genes
US11550395B2 (en) 2019-01-04 2023-01-10 Ultrahaptics Ip Ltd Mid-air haptic textures
CN114107385A (zh) * 2019-01-17 2022-03-01 百奥赛图(北京)医药科技股份有限公司 人源化转基因动物
SG11202108454RA (en) 2019-04-04 2021-09-29 Regeneron Pharma Non-human animals comprising a humanized coagulation factor 12 locus
US11842517B2 (en) 2019-04-12 2023-12-12 Ultrahaptics Ip Ltd Using iterative 3D-model fitting for domain adaptation of a hand-pose-estimation neural network
WO2020240876A1 (ja) * 2019-05-27 2020-12-03 株式会社トランスジェニック エクソンヒト化マウス
JP2022534867A (ja) 2019-06-04 2022-08-04 リジェネロン・ファーマシューティカルズ・インコーポレイテッド ベータスリップ変異を有するヒト化ｔｔｒ遺伝子座を含む非ヒト動物と使用方法
CN113939595A (zh) 2019-06-07 2022-01-14 瑞泽恩制药公司 包括人源化白蛋白基因座的非人动物
US11374586B2 (en) 2019-10-13 2022-06-28 Ultraleap Limited Reducing harmonic distortion by dithering
US11553295B2 (en) 2019-10-13 2023-01-10 Ultraleap Limited Dynamic capping with virtual microphones
WO2021090028A1 (en) 2019-11-08 2021-05-14 Ultraleap Limited Tracking techniques in haptics systems
CN111304246B (zh) * 2019-12-17 2021-05-04 百奥赛图江苏基因生物技术有限公司 一种人源化细胞因子动物模型、制备方法及应用
US11715453B2 (en) 2019-12-25 2023-08-01 Ultraleap Limited Acoustic transducer structures
EP4096396A1 (en) * 2020-01-28 2022-12-07 Regeneron Pharmaceuticals, Inc. Non-human animals comprising a humanized pnpla3 locus and methods of use
WO2021216505A1 (en) 2020-04-21 2021-10-28 Regeneron Pharmaceuticals, Inc. Non-human animals having a humanized cxcl13 gene
US11816267B2 (en) 2020-06-23 2023-11-14 Ultraleap Limited Features of airborne ultrasonic fields
WO2022058738A1 (en) 2020-09-17 2022-03-24 Ultraleap Limited Ultrahapticons
US20240224964A9 (en) 2022-09-29 2024-07-11 Regeneron Pharmaceuticals, Inc. Correction of hepatosteatosis in humanized liver animals through restoration of il6/il6r/gp130 signaling in human hepatocytes

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1996012025A1 (en) * 1994-10-14 1996-04-25 Basf Aktiengesellschaft TRANSGENIC NONHUMAN ANIMAL HAVING FUNCTIONALLY DISRUPTED INTERLEUKIN-1β CONVERTING ENZYME GENE
EP1884524A3 (en) 1994-10-21 2008-06-25 Chugai Seiyaku Kabushiki Kaisha Pharmaceutical composition for treatment of diseases caused by IL-6 production
US20030082721A1 (en) * 2001-01-17 2003-05-01 Tai-Jay Chang Transgenic animals expressing androgen receptor complex-associated protein
CN1560081A (zh) * 2004-02-17 2005-01-05 大连帝恩生物工程有限公司 用能产生人IgGl重链－κ轻链小鼠作为制备人源化单克隆抗体和应用
ES2463476T3 (es) 2004-10-19 2014-05-28 Regeneron Pharmaceuticals, Inc. Método para generar un ratón homocigótico para una modificación genética
US7759541B2 (en) 2004-12-13 2010-07-20 Iti Life Sciences Transgenic animals for assessing drug metabolism and toxicity
GB2434578A (en) 2006-01-26 2007-08-01 Univ Basel Transgenic animals
PL2041177T3 (pl) 2006-06-02 2012-09-28 Regeneron Pharma Przeciwciała o wysokim powinowactwie przeciw ludzkiemu receptorowi IL 6
JP5087625B2 (ja) * 2006-09-01 2012-12-05 セラピューティック・ヒューマン・ポリクローナルズ・インコーポレーテッド 非ヒトトランスジェニック動物におけるヒトまたはヒト化免疫グロブリンの発現強化
FR2942218A1 (fr) 2009-02-13 2010-08-20 Eurocave Sa Appareil de service au verre d'un liquide, notamment de vin
DK3056082T3 (en) 2009-10-06 2018-12-17 Regeneron Pharma RE-MODIFIED MICE AND INPUT
SG10201408415PA (en) * 2009-12-21 2015-01-29 Regeneron Pharma HUMANIZED FCγ R MICE
ES2948210T3 (es) 2011-02-15 2023-09-06 Regeneron Pharma Ratones humanizados con M-CSF y uso de los mismos
CA2850322C (en) * 2011-09-30 2023-10-10 Chugai Seiyaku Kabushiki Kaisha Antigen-binding molecule inducing immune response to target antigen
PL3262932T3 (pl) 2011-10-28 2019-10-31 Regeneron Pharma Genetycznie zmodyfikowany główny układ zgodności tkankowej myszy
KR101926442B1 (ko) 2011-10-28 2018-12-12 리제너론 파아마슈티컬스, 인크. 키메라 주요 조직적합성 복합체 （ｍｈｃ） ｉｉ 분자들을 발현하는 유전자 변형된 마우스
PT2663575E (pt) 2011-10-28 2014-12-05 Regeneron Pharma Il-6 e receptor de il-6 humanizados

Also Published As

Publication number Publication date
IL264508B (en) 2019-12-31
US20180271071A1 (en) 2018-09-27
IL231896A0 (en) 2014-05-28
HRP20170656T1 (hr) 2017-06-30
CN104039821A (zh) 2014-09-10
RU2017129763A3 (hr) 2020-12-18
HK1190408A1 (en) 2014-07-04
CA2853731C (en) 2021-05-18
WO2013063556A8 (en) 2014-04-17
US20200008407A1 (en) 2020-01-09
EP2818478A1 (en) 2014-12-31
RU2634417C2 (ru) 2017-10-26
KR102084927B1 (ko) 2020-03-06
IL231896B (en) 2018-02-28
US9392777B2 (en) 2016-07-19
MX2014004900A (es) 2014-08-26
PL2818478T3 (pl) 2017-09-29
HUE033400T2 (en) 2017-12-28
KR102234632B1 (ko) 2021-04-02
RS55949B1 (sr) 2017-09-29
SG10202100485XA (en) 2021-02-25
LT2818478T (lt) 2017-06-12
PL2663575T3 (pl) 2015-03-31
IN2014CN03920A (hr) 2015-09-04
SI2663575T1 (sl) 2015-01-30
ES2624605T3 (es) 2017-07-17
US11102962B2 (en) 2021-08-31
JP6120451B2 (ja) 2017-04-26
KR20140091024A (ko) 2014-07-18
JP2017035115A (ja) 2017-02-16
AU2015207889B2 (en) 2017-02-23
CY1118952T1 (el) 2018-01-10
IL243666A0 (en) 2016-03-31
BR112014008529A2 (pt) 2017-04-18
DK2818478T3 (en) 2017-05-22
EP2663575A1 (en) 2013-11-20
WO2013063556A4 (en) 2013-06-20
DK2663575T3 (en) 2014-12-15
MX358390B (es) 2018-08-17
US9125386B2 (en) 2015-09-08
ZA201402635B (en) 2015-09-30
US10433528B2 (en) 2019-10-08
RS53683B1 (en) 2015-04-30
PT2663575E (pt) 2014-12-05
NZ623145A (en) 2015-09-25
CA2853731A1 (en) 2013-05-02
AU2015207889A1 (en) 2015-08-20
MY172726A (en) 2019-12-11
CN108866101A (zh) 2018-11-23
SG11201400945UA (en) 2014-04-28
EP2663575B1 (en) 2014-10-01
US9622460B2 (en) 2017-04-18
US20130117873A1 (en) 2013-05-09
US20170055506A1 (en) 2017-03-02
WO2013063556A1 (en) 2013-05-02
JP2014532416A (ja) 2014-12-08
IL264508A (en) 2019-02-28
SI2818478T1 (sl) 2017-07-31
US20220053742A1 (en) 2022-02-24
RU2017129763A (ru) 2019-02-05
SG10201600965YA (en) 2016-03-30
KR20200024949A (ko) 2020-03-09
US20150272092A1 (en) 2015-10-01
HK1205135A1 (en) 2015-12-11
IL243665B (en) 2018-02-28
US20160278352A1 (en) 2016-09-29
IL243665A0 (en) 2016-03-31
IL243666B (en) 2019-02-28
US10004211B2 (en) 2018-06-26
EP2818478B1 (en) 2017-02-01
MY186903A (en) 2021-08-26
CY1116614T1 (el) 2017-03-15
RU2751240C2 (ru) 2021-07-12
US20150013023A1 (en) 2015-01-08
US9078418B2 (en) 2015-07-14
ES2525368T3 (es) 2014-12-23
SMT201400187B (it) 2015-01-15
US20150013022A1 (en) 2015-01-08
PT2818478T (pt) 2017-05-12
US8878001B2 (en) 2014-11-04
NZ709432A (en) 2015-12-24
RU2014121324A (ru) 2015-12-10

Similar Documents

Publication Publication Date Title
HRP20141192T1 (hr) Humanizirani il-6 i receptor il-6
JP2014532416A5 (hr)
JP6930695B2 (ja) 動物モデルおよび治療用分子
JP2015523863A5 (hr)
JP6600061B2 (ja) ヒト化ｉｌ−１５動物
US11937587B2 (en) Non-human animals expressing humanized CD3 complex
ES2626965T3 (es) Roedores con IL-7 humanizada
Ryder et al. Molecular characterization of mutant mouse strains generated from the EUCOMM/KOMP-CSD ES cell resource
HRP20211455T1 (hr) Životinje s humaniziranim il-4 i il-4r alfa
JP2016510998A5 (hr)
SI2770821T1 (en) Genetically modified major histocompatibility complex of mice
MX2016009243A (es) Métodos de mutagénesis.
JP2017514496A5 (hr)
MX369747B (es) Modificación dirigida del genoma de rata.
FI3823443T3 (fi) Ditra-taudin jyrsijämallit ja niiden käyttö
Wang et al. Pno1 tissue-specific expression and its functions related to the immune responses and proteasome activities
Watanabe et al. Generation of a conditional null allele of Lbx1
CN115873876A (zh) Fap基因人源化的非人动物的构建方法及应用
Scardoni Next generation exome sequencing of Pancreatic Neuroendocrine Neoplasms (PanNENs)
NZ766708A (en) Transgenic mice expressing chimeric major histocompatibility complex (mhc) class ii molecules
Iamartino et al. Sequencing of the water buffalo genome: results and perspectives
Salvaris et al. Generation of Transgenic Pigs Co-Expressing Human Thrombomodulin and CD39: 1527
Rende Kinetics and regulation of HTLV-1 gene expression
HAN Generation of brevican knockout mice
Facchinello Conditional inactivation of Emilin1 and Col6a1 genes